Personalized patient insights

OWise provides quantitative information about side effects, symptoms and emotional state from a patient’s moment of diagnosis. This helps with the delivery of more focused and personalized patient care. When OWise is integrated into the hospital’s electronic medical record system, patient wellbeing information can be accessed in real-time. 

Improved communication

Fostering a closer, and a more collaborative relationship can help drive improved clinical outcomes. By collating information and insights, OWise supports patients with a report that significantly enhances patient-provider communication. By providing users with a list of tailored questions, OWise can prompt informed dialogue.

Evidence-based and validated

OWise has undergone substantial validation studies reporting that 9 out of 10 clinicians would recommend it to their patients. A Randomized Controlled Trial by the UK’s Royal Marsden Hospital is currently ongoing. OWise is approved and recommended by the UK’s National Health Service. Also, a recent systematic review showed OWise to be the best-rated breast cancer app. 

• National Health Service (UK) 
• Royal Marsden Hospital (UK) 

Creating value for cancer patients, healthcare providers and cancer research

Digital symptom management is shown to improve patients’ overall survival and quality of life.

Kaiku’s unique algorithms screen symptoms, alert care team and provide support for cancer patients. This along with the capture and analysis of real world data paves way for more personalised and value-based healthcare.

Personalised support and improved quality of life for patients

Kaiku Health is a patient’s companion throughout different phases of therapy. It reduces uncertainty around symptoms by educating patients on their self-management strategies. Digital symptom monitoring can help cancer patients live longer, reduce ER visits and improve their quality of life.

Improved symptom management for care teams

Algorithms triage patients’ symptom reports, which helps clinical staff prioritise their daily work. Multidisciplinary care teams have access to a comprehensive decision support dashboard, which enables intervening to symptoms early. Clinics using Kaiku Health report decreased phone call burden and more efficient patient visits and contacts.

Real world data on the effectiveness of therapies for cancer research

Regulatory-grade patient-reported outcomes data combined with clinical data opens significant new opportunities for evaluating the safety profile and effectiveness of treatments and their long-term outcomes in a real-world setting. This enables the development of new, better targeted ways to treat cancer.

• Docrates (Finland)
• Elbe Kliniken (Germany) 
• Hirslanden Radiotherapie (Switzerland)
• HUS (Finland) 
• Istituto Nazionale dei Tumori (Italy) 
• Klinikum Fürth (Germany) 
• Netherlands Cancer Institute
• Oulu University Hospital (Finland) 
• Strahlentherapie München-Schwabing (Germany)
• Tumor Zentrum Aarau (Switzerland) 
• Turku University Hospital (Finland)  
• UKSH - Universitätsklinikum Schleswig-Holstein (Germany)